HempFusion Wellness Inc. To Report First Quarter 2021 Earnings and Host Conference Call on May 17, 2021 May 11, 2021
Hemostemix Provides a Clinical Trial Update and Announces the Release and Filing of 2020 Year-end Audited Financial Statements and Management Discussion and Analysis Apr 30, 2021
Rethinking the approach to diagnose cancer | VolitionRx Limited Apr 30, 2021 Life Science, Technology
Hemostemix Reprices and Amends the Terms of Its Unit Offering and Debenture Offering Apr 26, 2021 Life Science, Technology
Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up and HMTXF Up-list Apr 23, 2021 Life Science, Technology
HempFusion Comments on Recent Trading Activity, All Projects, Incl. Five Channel Strategy, in Motion and Strong Cash-On-Hand Apr 15, 2021 Life Science, Technology
Sanofi Unveils First Global Research Institute in China to Develop Innovative Drugs Apr 14, 2021 Life Science
HempFusion Completes Inflammatory Markers Pilot Trial, Releases White Paper Mar 25, 2021 Life Science
HempFusion Wellness Announces Toxicology Results from Validcare’s Clinical Study on CBD Liver Safety Mar 23, 2021 Life Science
What Does HempFusion Entry onto China’s Ecommerce Giant, Tmall, Mean for Investors? Mar 18, 2021 Life Science
HempFusion Wellness Enters China with Probulin Probiotics Through Alibaba Group’s T-Mall Global, Reaching More Than 750 Million Potential New Consumers Mar 18, 2021 Life Science
HempFusion Is the Top Performing Topical CBD Brand at Major Food-Drug Mass Retailer Mar 9, 2021 Life Science
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency Mar 3, 2021 Life Science
